Compare $ATYR vs $BYSI | Chartloom

Compare

$ATYR vs $BYSI

aTyr Pharma Inc · Beyondspring Inc

ATYR

aTyr Pharma Inc

BYSI

Beyondspring Inc

Compare $ATYR vs $BYSI

Comparing aTyr Pharma Inc and Beyondspring Inc

ATYRaTyr Pharma Inc

BYSIBeyondspring Inc

ATYRaTyr Pharma Inc

Market cap

$24M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.1%

YTD performance

-67.6%

52W performance

-75.4%

FCF yield

-227.1%

BYSIBeyondspring Inc

Market cap

$25M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-62.4%

52W performance

-66.2%

FCF yield

-67.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATYR

BYSI

Detailed metrics comparison

ATYR

aTyr Pharma Inc

BYSI

Beyondspring Inc

Market Cap

ATYR$24M

BYSI$25M

Enterprise Value

ATYR$9M

BYSI$22M

Price

ATYR$0.25

BYSI$0.61

P/E Ratio

ATYRN/A

BYSIN/A

P/S Ratio

ATYR127.05x

BYSI23.96x

EV/Sales

ATYR44.92x

BYSI21.97x

EV/EBITDA

ATYR0.00x

BYSI0.00x

P/B Ratio

ATYR0.58x

BYSI3.99x

P/FCF Ratio

ATYRN/A

BYSIN/A

EV/FCF

ATYR-0.16x

BYSI-1.33x

PEG Ratio

ATYRN/A

BYSIN/A

Forward P/E (NTM)

ATYRN/A

BYSIN/A

Forward P/S (NTM)

ATYRN/A

BYSIN/A

Revenue (TTM)

ATYR$190K

BYSI$0

Revenue Growth (YoY)

ATYR-19.1%

BYSIN/A

Forward Rev Growth

ATYR2461.0%

BYSI0.0%

Gross Margin (TTM)

ATYR0.0%

BYSI0.0%

Operating Margin (TTM)

ATYR0.0%

BYSI0.0%

EBITDA Margin (TTM)

ATYR-21689.5%

BYSI0.0%

Net Margin (TTM)

ATYR-20898.4%

BYSI0.0%

FCF Margin (TTM)

ATYR-28852.1%

BYSIN/A

Net Income (TTM)

ATYR$-40M

BYSI$-7M

FCF (TTM)

ATYR$-55M

BYSI$-17M

EPS (TTM)

ATYR$0.00

BYSI-$0.16

ROE (TTM)

ATYR-9962.0%

BYSI-13313.0%

ROA (TTM)

ATYR-7441.0%

BYSI-3024.0%

ROIC (TTM)

ATYR-9817.0%

BYSI-12817.0%

Cash

ATYR$16M

BYSI$3M

Debt

ATYR$554K

BYSI$0

Net Cash/Debt

ATYR$16M

BYSI$3M

Current Ratio (TTM)

ATYR5.12x

BYSI0.70x

Quick Ratio (TTM)

ATYR5.08x

BYSI0.66x

Debt/Equity (TTM)

ATYR0.01x

BYSI0.06x

Debt/Assets (TTM)

ATYR0.0%

BYSI0.0%

Interest Coverage (TTM)

ATYRN/A

BYSIN/A

Net Debt/EBITDA (TTM)

ATYR0.00x

BYSI0.00x

Beta

ATYR0.99

BYSI-0.26

52W Performance

ATYR-75.4%

BYSI-66.2%

YTD Performance

ATYR-67.6%

BYSI-62.4%

% from 52W High

ATYR-78.0%

BYSI-75.2%

% from 52W Low

ATYR0.1%

BYSI7.1%

Asset Turnover (TTM)

ATYR0.00x

BYSI0.02x

FCF Yield (TTM)

ATYR-227.1%

BYSI-67.2%

Earnings Yield (TTM)

ATYR-164.5%

BYSI-26.8%

Dividend Yield (TTM)

ATYRN/A

BYSIN/A

Rule of 40

ATYR-28,871.3

BYSI0.0

EV/GP/RG

ATYRN/A

BYSIN/A

Ticker research

View ATYR research View BYSI research

Metric	ATYR aTyr Pharma Inc	BYSI Beyondspring Inc
Market & Valuation
Market Cap	$24M	$25M
Enterprise Value	$9M	$22M
Price	$0.25	$0.61
P/E Ratio	N/A	N/A
P/S Ratio	127.05x	23.96x
EV/Sales	44.92x	21.97x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.58x	3.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.16x	-1.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$190K	$0
Revenue Growth (YoY)	-19.1%	N/A
Forward Rev Growth	2461.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-21689.5%	0.0%
Net Margin (TTM)	-20898.4%	0.0%
FCF Margin (TTM)	-28852.1%	N/A
Net Income (TTM)	$-40M	$-7M
FCF (TTM)	$-55M	$-17M
EPS (TTM)	$0.00	-$0.16
ROE (TTM)	-9962.0%	-13313.0%
ROA (TTM)	-7441.0%	-3024.0%
ROIC (TTM)	-9817.0%	-12817.0%
Financial Health
Cash	$16M	$3M
Debt	$554K	$0
Net Cash/Debt	$16M	$3M
Current Ratio (TTM)	5.12x	0.70x
Quick Ratio (TTM)	5.08x	0.66x
Debt/Equity (TTM)	0.01x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	-0.26
52W Performance	-75.4%	-66.2%
YTD Performance	-67.6%	-62.4%
% from 52W High	-78.0%	-75.2%
% from 52W Low	0.1%	7.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-227.1%	-67.2%
Earnings Yield (TTM)	-164.5%	-26.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-28,871.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATYR research	View BYSI research

Valuation

P/S Ratio

BYSI

23.96x

ATYR

127.05x

EV/FCF

BYSI

-1.33x

ATYR

-0.16x

Growth & revenue

Revenue Growth TTM

ATYR

-19.1%

Forward Revenue Growth

ATYR

2461.0%

BYSI

0.0%

Profitability & performance

Gross Margin

ATYR

0.0%

BYSI

0.0%

ROE

ATYR

-9962.0%

BYSI

-13313.0%

FCF Yield %

BYSI

-67.2%

ATYR

-227.1%

52-Week Performance

BYSI

-66.2%

ATYR

-75.4%

Detailed metrics comparison

ATYR

aTyr Pharma Inc

BYSI

Beyondspring Inc

Market Cap

ATYR$24M

BYSI$25M

Enterprise Value

ATYR$9M

BYSI$22M

Price

ATYR$0.25

BYSI$0.61

P/E Ratio

ATYRN/A

BYSIN/A

P/S Ratio

ATYR127.05x

BYSI23.96x

EV/Sales

ATYR44.92x

BYSI21.97x

EV/EBITDA

ATYR0.00x

BYSI0.00x

P/B Ratio

ATYR0.58x

BYSI3.99x

P/FCF Ratio

ATYRN/A

BYSIN/A

EV/FCF

ATYR-0.16x

BYSI-1.33x

PEG Ratio

ATYRN/A

BYSIN/A

Forward P/E (NTM)

ATYRN/A

BYSIN/A

Forward P/S (NTM)

ATYRN/A

BYSIN/A

Revenue (TTM)

ATYR$190K

BYSI$0

Revenue Growth (YoY)

ATYR-19.1%

BYSIN/A

Forward Rev Growth

ATYR2461.0%

BYSI0.0%

Gross Margin (TTM)

ATYR0.0%

BYSI0.0%

Operating Margin (TTM)

ATYR0.0%

BYSI0.0%

EBITDA Margin (TTM)

ATYR-21689.5%

BYSI0.0%

Net Margin (TTM)

ATYR-20898.4%

BYSI0.0%

FCF Margin (TTM)

ATYR-28852.1%

BYSIN/A

Net Income (TTM)

ATYR$-40M

BYSI$-7M

FCF (TTM)

ATYR$-55M

BYSI$-17M

EPS (TTM)

ATYR$0.00

BYSI-$0.16

ROE (TTM)

ATYR-9962.0%

BYSI-13313.0%

ROA (TTM)

ATYR-7441.0%

BYSI-3024.0%

ROIC (TTM)

ATYR-9817.0%

BYSI-12817.0%

Cash

ATYR$16M

BYSI$3M

Debt

ATYR$554K

BYSI$0

Net Cash/Debt

ATYR$16M

BYSI$3M

Current Ratio (TTM)

ATYR5.12x

BYSI0.70x

Quick Ratio (TTM)

ATYR5.08x

BYSI0.66x

Debt/Equity (TTM)

ATYR0.01x

BYSI0.06x

Debt/Assets (TTM)

ATYR0.0%

BYSI0.0%

Interest Coverage (TTM)

ATYRN/A

BYSIN/A

Net Debt/EBITDA (TTM)

ATYR0.00x

BYSI0.00x

Beta

ATYR0.99

BYSI-0.26

52W Performance

ATYR-75.4%

BYSI-66.2%

YTD Performance

ATYR-67.6%

BYSI-62.4%

% from 52W High

ATYR-78.0%

BYSI-75.2%

% from 52W Low

ATYR0.1%

BYSI7.1%

Asset Turnover (TTM)

ATYR0.00x

BYSI0.02x

FCF Yield (TTM)

ATYR-227.1%

BYSI-67.2%

Earnings Yield (TTM)

ATYR-164.5%

BYSI-26.8%

Dividend Yield (TTM)

ATYRN/A

BYSIN/A

Rule of 40

ATYR-28,871.3

BYSI0.0

EV/GP/RG

ATYRN/A

BYSIN/A

Ticker research

View ATYR research View BYSI research

Metric	ATYR aTyr Pharma Inc	BYSI Beyondspring Inc
Market & Valuation
Market Cap	$24M	$25M
Enterprise Value	$9M	$22M
Price	$0.25	$0.61
P/E Ratio	N/A	N/A
P/S Ratio	127.05x	23.96x
EV/Sales	44.92x	21.97x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.58x	3.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.16x	-1.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$190K	$0
Revenue Growth (YoY)	-19.1%	N/A
Forward Rev Growth	2461.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-21689.5%	0.0%
Net Margin (TTM)	-20898.4%	0.0%
FCF Margin (TTM)	-28852.1%	N/A
Net Income (TTM)	$-40M	$-7M
FCF (TTM)	$-55M	$-17M
EPS (TTM)	$0.00	-$0.16
ROE (TTM)	-9962.0%	-13313.0%
ROA (TTM)	-7441.0%	-3024.0%
ROIC (TTM)	-9817.0%	-12817.0%
Financial Health
Cash	$16M	$3M
Debt	$554K	$0
Net Cash/Debt	$16M	$3M
Current Ratio (TTM)	5.12x	0.70x
Quick Ratio (TTM)	5.08x	0.66x
Debt/Equity (TTM)	0.01x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	-0.26
52W Performance	-75.4%	-66.2%
YTD Performance	-67.6%	-62.4%
% from 52W High	-78.0%	-75.2%
% from 52W Low	0.1%	7.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-227.1%	-67.2%
Earnings Yield (TTM)	-164.5%	-26.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-28,871.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ATYR research	View BYSI research